Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
1.47B | 1.33B | 1.20B | 972.18M | 794.25M |
Gross Profit | ||||
404.65M | 197.79M | 148.29M | 197.58M | 165.79M |
EBIT | ||||
22.91M | -208.91M | -260.99M | -114.50M | -80.78M |
EBITDA | ||||
22.91M | -135.13M | -198.89M | -60.14M | -42.44M |
Net Income Common Stockholders | ||||
-29.23M | -302.12M | -315.09M | -193.37M | -179.09M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
802.85M | 664.59M | 348.50M | 396.04M | 246.95M |
Total Assets | ||||
2.66B | 2.41B | 1.95B | 1.73B | 1.45B |
Total Debt | ||||
1.53B | 1.45B | 1.02B | 1.12B | 913.37M |
Net Debt | ||||
726.92M | 790.09M | 671.10M | 726.60M | 666.43M |
Total Liabilities | ||||
2.07B | 1.89B | 1.57B | 1.73B | 1.31B |
Stockholders Equity | ||||
562.47M | 502.08M | 340.78M | -44.33M | 78.82M |
Cash Flow | Free Cash Flow | |||
33.15M | -456.27M | -308.55M | -110.49M | -136.61M |
Operating Cash Flow | ||||
92.00M | -372.53M | -191.72M | -60.68M | -98.69M |
Investing Cash Flow | ||||
-58.78M | -83.72M | -116.82M | -46.70M | -37.91M |
Financing Cash Flow | ||||
175.21M | 683.35M | 220.55M | 306.38M | 175.93M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
66 Neutral | $2.16B | 6.07 | 25.00% | 2.04% | -12.01% | -38.33% | |
63 Neutral | $4.14B | 11.23 | 5.47% | 215.40% | 4.10% | -8.63% | |
56 Neutral | $3.89B | ― | -5.49% | ― | 10.53% | 90.76% | |
49 Neutral | $112.83M | ― | -283.03% | ― | 46.76% | 19.94% | |
45 Neutral | $849.93M | ― | -90.88% | ― | -29.45% | -10.79% | |
42 Neutral | $78.87M | ― | -18.96% | ― | 11.09% | 0.41% | |
33 Underperform | $1.05B | ― | 125.43% | ― | -4.71% | -117.58% |
Bloom Energy’s Board of Directors has decided to cancel 1,150,000 performance-based stock units from the equity package previously awarded to Dr. Sridhar, aligning with the company’s updated strategic priorities. In place of the 2021 PSUs, a new equity package has been approved, offering Dr. Sridhar a front-loaded three-year equity award and a one-time grant, aimed at incentivizing performance aligned with the company’s goals and retaining his leadership through 2027.